Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges (Q59019514)

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Lung cancer: New biological insights and recent therapeutic advances

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Photodynamic therapy of cancer: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Polyethylene glycol-modified gelatin/polylactic acid nanoparticles for enhanced photodynamic efficacy of a hypocrellin derivative in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Immune therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

State-of-the-art gene-based therapies: the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Virus-mediated gene delivery for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Progress and prospects: immune responses to viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Nanoparticle delivery of cancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Efficacy and safety of Abraxane in treatment of progressive and recurrent non-small cell lung cancer patients: A retrospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Cationic liposomes for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Clinical applications of virosomes in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Novel temperature-sensitive liposomes with prolonged circulation time

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Archaeosome adjuvant overcomes tolerance to tumor-associated melanoma antigens inducing protective CD8 T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Cisplatin nephrotoxicity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Liposomal paclitaxel formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Vaccination with BLP25 liposome vaccine to treat non-small cell lung and prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Antitumor effects of L-BLP25 antigen-specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Optically traceable solid lipid nanoparticles loaded with siRNA and paclitaxel for synergistic chemotherapy with in situ imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Lomustine loaded chitosan nanoparticles: characterization and in-vitro cytotoxicity on human lung cancer cell line L132.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Noble metal nanoparticles applications in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Classification of lung cancer histology by gold nanoparticle sensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Selective targeting of antibody conjugated multifunctional nanoclusters (nanoroses) to epidermal growth factor receptors in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Size-dependent photodynamic activity of gold nanoparticles conjugate of water soluble purpurin-18-N-methyl-d-glucamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Endocytosis of a single mesoporous silica nanoparticle into a human lung cancer cell observed by differential interference contrast microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Multifunctional nanoparticles for drug delivery and molecular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Nanomedicine in Action: An Overview of Cancer Nanomedicine on the Market and in Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Nanotoxicology - a pathologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Mechanisms of toxicity of amorphous silica nanoparticles on human lung submucosal cells in vitro: protective effects of fisetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Mechanisms of nanoparticle-induced oxidative stress and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F863951